======= MICAL2 =======
== Gene Information ==
* **Official Symbol**: MICAL2
* **Official Name**: microtubule associated monooxygenase, calponin and LIM domain containing 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9645|9645]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O94851|O94851]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=MICAL2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MICAL2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/608881|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene is a monooxygenase that enhances depolymerization of F-actin and is therefore involved in cytoskeletal dynamics. The encoded protein is a regulator of the SRF signaling pathway. Increased expression of this gene has been associated with cancer progression and metastasis. [provided by RefSeq, Oct 2016].
* **UniProt Summary**: Nuclear monooxygenase that promotes depolymerization of F-actin by mediating oxidation of specific methionine residues on actin to form methionine-sulfoxide, resulting in actin filament disassembly and preventing repolymerization. In the absence of actin, it also functions as a NADPH oxidase producing H(2)O(2) (By similarity). Acts as a key regulator of the SRF signaling pathway elicited by nerve growth factor and serum: mediates oxidation and subsequent depolymerization of nuclear actin, leading to increase MKL1/MRTF-A presence in the nucleus and promote SRF:MKL1/MRTF-A- dependent gene transcription. Does not activate SRF:MKL1/MRTF-A through RhoA. {ECO:0000250|UniProtKB:Q8BML1, ECO:0000250|UniProtKB:Q8TDZ2, ECO:0000269|PubMed:24440334}.
|LIM|
|Pyr redox 2|
|FAD binding 3|
|CH|
|CAMSAP CH|
|FAD binding 2|
|NADPH:sulfur oxidoreductase activity|
|sulfur oxidation|
|positive regulation of transcription via serum response element binding|
|NAD(P)H oxidase activity|
|actin filament depolymerization|
|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen|
|FAD binding|
|protein depolymerization|
|actin polymerization or depolymerization|
|heart looping|
|embryonic heart tube morphogenesis|
|determination of heart left/right asymmetry|
|embryonic heart tube development|
|determination of left/right symmetry|
|oxidoreductase activity|
|determination of bilateral symmetry|
|specification of symmetry|
|cellular protein complex disassembly|
|protein-containing complex disassembly|
|actin filament organization|
|heart morphogenesis|
|actin binding|
|embryonic organ morphogenesis|
|epithelial tube morphogenesis|
|sulfur compound metabolic process|
|cellular component disassembly|
|morphogenesis of an epithelium|
|embryonic organ development|
|pattern specification process|
|supramolecular fiber organization|
|actin cytoskeleton organization|
|heart development|
|tissue morphogenesis|
|embryonic morphogenesis|
|actin filament-based process|
|tube morphogenesis|
|tube development|
|circulatory system development|
|animal organ morphogenesis|
|oxidation-reduction process|
|embryo development|
|cytoskeleton organization|
|epithelium development|
|positive regulation of transcription by RNA polymerase II|
|positive regulation of transcription, DNA-templated|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|positive regulation of RNA metabolic process|
|tissue development|
|protein-containing complex subunit organization|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp288|HMS-I2 10μM R06 exp288]]|-2.13|
|[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-1.86|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 6279
* **Expression level (log2 read counts)**: 2.84
{{:chemogenomics:nalm6 dist.png?nolink |}}